Cargando…

The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review

Dementia is one of the major causes of disability and hospitalization in the elderly. As far as non-invasive markers of dementia are concerned, we only have age and Apolipoprotein-E (Apo-E) gene, which can be considered as clinically relevant. Modifiable risk factors have been found to be the cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anusheel, Avula, Supraja N, Joseph, Ke-li-ta N, Onuchukwu, Chibuzor V, Thondamala, Vishwanath, Shrivastava, Shashwat, Namburi, Anusha R, Mohammed, Lubna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126470/ https://www.ncbi.nlm.nih.gov/pubmed/35621297 http://dx.doi.org/10.7759/cureus.24374

Ejemplares similares

Emphasis on Early Identification of Risk Factors to Curtail High Mortality Involved With Ischemic Colitis (IC) After Abdominal Aortic Aneurysm (AAA) Repair
por: Shrivastava, Shashwat, et al.
Publicado: (2022)

The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Predicting the Severity of Proteinuria and Renal Dysfunction in Primary Nephrotic Syndrome
por: Yılmaz Aydın, Fatma, et al.
Publicado: (2021)

The Relationship Between Diabetic Neuropathy and Uric Acid/High-Density Lipoprotein Ratio in Patients With Type-2 Diabetes Mellitus
por: Uzeli, Ulkem, et al.
Publicado: (2023)

The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Gosal, Harpreet, et al.
Publicado: (2021)

Relevance of serum concentrations of non-esterified fatty acids and very low-density lipoproteins in nulli/primiparous and multiparous cows in the close-up period
por: OIKAWA, Shin, et al.
Publicado: (2017)

Association of Low Levels of Soluble Low-Density Lipoprotein Receptor-Related Protein-1 and COVID-19 Outcomes During the First Wave of Pandemic
por: Agirbasli, Mehmet, et al.
Publicado: (2023)

Retinal Artery Occlusion and Associated Risk of Cerebrovascular Disease Related Hospitalization: A National Inpatient Study
por: Kaur, Manpreet, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Gut Microbiota Interventions for the Management of Obesity: A Literature Review
por: Gill, Vikram Jeet Singh, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol lowering treatment: the current approach
por: Crismaru, Irina, et al.
Publicado: (2020)

Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia
por: Kim, Woojin Scott, et al.
Publicado: (2018)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Association of Serum Bilirubin and Lipid Ratio (Total Cholesterol/(High-Density Lipoprotein + Bilirubin)) in Coronary Artery Disease: A Case-Control Study at a Tertiary Care Hospital
por: Adepu, Chiradeep, et al.
Publicado: (2023)

Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes: Focus on Combination Therapy with Colesevelam HCl
por: Marrs, Joel C.
Publicado: (2012)

Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
por: Shapiro, Michael D., et al.
Publicado: (2019)

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
por: Szarek, Michael, et al.
Publicado: (2020)

Association of Hyper-Low-Density Lipoprotein and Hypo-High-Density Lipoprotein Cholesterolemia with Low Saliva Flow Rates in Japanese Community-Dwelling Elders
por: Mizoguchi, Nana, et al.
Publicado: (2022)

Multidrug resistant Gram-negative bacilli in lower respiratory tract infections
por: Vishwanath, Shashidhar, et al.
Publicado: (2013)

The Key Role of Glutathione Compared to Curcumin in the Management of Systemic Lupus Erythematosus: A Systematic Review
por: Ravi, Niriksha, et al.
Publicado: (2022)

Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome
por: Biswas, Hope H., et al.
Publicado: (2015)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
por: Ballantyne, Christie M., et al.
Publicado: (2022)

An Unusual Initial Presentation of Elderly-Onset Crohn’s Disease
por: Raddawi, Kenan, et al.
Publicado: (2020)

Rhinovirus-induced Rapidly Progressing Acute Respiratory Distress Syndrome in an Immunocompetent Host
por: Ngu, Sam, et al.
Publicado: (2019)

Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography
por: MIZUTANI, Hisashi, et al.
Publicado: (2016)

LC-MS/MS Analysis of Canine Lipoproteins Fractionated Using the Ultracentrifugation-Precipitation Method
por: SUTO, Asuka, et al.
Publicado: (2013)

Unilateral Purple Urine Bag Syndrome in an Elderly Man with Nephrostomy
por: Amoozgar, Behzad, et al.
Publicado: (2019)

A Case of Rapidly Progressive Dementia
por: Thekkekarott Kuruvila, Arun, et al.
Publicado: (2022)

Anticoagulants and Dementia: A Systematic Review
por: Kalloo, Amy E, et al.
Publicado: (2023)

Internal Carotid Artery Dissection with Lidocaine Nerve Block Injection Trauma: A Rare Case Report
por: Narula, Naureen, et al.
Publicado: (2018)

Left-sided Catamenial Pneumothorax: A Rare Clinical Entity
por: Narula, Naureen, et al.
Publicado: (2018)

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
por: Bays, Harold E
Publicado: (2014)

Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
por: Abdalwahab, Ahmed, et al.
Publicado: (2021)

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021)

A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology
por: Nestel, Paul J., et al.
Publicado: (2023)

Headache - A Window to Dementia: An Unexpected Twist
por: Sharif, Shayka, et al.
Publicado: (2021)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qeio8hs38ra003n58alo3a6fgk